Manvir, a young cancer patient, worked with the UCSF Benioff Oakland Braddock Emotional Support Team (BEST) to alleviate his emotional and physical pain from his treatments. A new gift will help expand BEST behavioral and mental health services to young cancer patients and their families.

Gal-3C, a galectin-3 inhibitor, shows promise in limiting post-MI scarring, improving cardiac function, and outperforming current therapies.

UCSF Benioff Children’s Hospital Oakland is the first hospital in the West to administer a newly approved gene therapy to treat beta thalassemia with gene therapy, reducing the need for lifelong blood transfusions.

The United States health system is poorly equipped to serve patients living alone who are also experiencing cognitive decline.

Study finds DOACs may lower recurrent VTE risk over warfarin in extended treatment. Observational evidence supports DOAC use.

A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.

A newly identified platelet factor 4 (PF4) was found to help rejuvenate the old brain and boost the young brain, potentially opening the door to new therapies that aim to restore brain function

Increasing wildfires means there is more wildfire smoke, which is particularly harmful for our bodies.

UCSF Langley Porter Psychiatric Hospital will welcome patients to a larger and modernized space on August 19 in UCSF Mount Zion Medical Center.

A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.